RDHL
Redhill Biopharma Ltd
NASDAQ: RDHL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.04
+0.00% today
Updated 2026-04-29
Market cap
$5.27M
P/E ratio
0.00
P/S ratio
0.55x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$1 – $3
Volume
0.0M
Redhill Biopharma Ltd (RDHL) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |